Question explored with the scientific record
Iodine suplementation for thyroid and prostate health
Iodine helps a deficient thyroid. It does not treat prostate disease, and the prostate evidence is animal and lab work only.
For thyroid, the picture depends on who you are. In iodine-deficient pregnant women, supplementation lowered TSH and thyroglobulin, mainly with 200–300 µg/day of potassium iodide [1]. But it did not move free T3, free T4, or thyroid antibodies [1][2]. In a Gambian randomized trial, prenatal iodine made no difference to maternal thyroid function at all [2]. In iodine-deficient overweight women, it cut TSH and total cholesterol [5].
The risk is real when you are not deficient. In a Spanish study, high supplement intake was linked to thyroid dysfunction even in iodine-sufficient women [4]. Urinary iodine above 300 µg/L carries a risk of iodine-induced hyperthyroidism and autoimmune thyroid disease [10]. Iodine will not reverse established hypothyroidism from cretinism: only 1 of 28 patients normalized TSH [3].
| Finding | What the evidence shows |
|---|---|
| TSH in deficient pregnant women | Fell with 200–300 µg/day [1] |
| Free T3/T4, antibodies | No significant change [1][2] |
| TSH normalization in cretinism | 1 of 28 patients [3] |
| High intake in sufficient women | Linked to dysfunction [4] |
| Urinary iodine ≥300 µg/L | Excess; autoimmune risk [10] |
For prostate health, there is no human evidence here. One rat study found molecular iodine prevented testosterone-induced prostate hyperplasia [6]. One lab study found iodine slowed prostate cancer cells [8]. Those are animals and petri dishes, not men. The brachytherapy records use radioactive iodine-125 as a radiation seed, which is a different thing entirely and not supplementation [7][9].
My call: test your urinary iodine first, supplement only if you are deficient, and do not take iodine for your prostate on this evidence. Confidence: moderate for thyroid, low for prostate.
Sources used 10
-
Effects of different iodine supplementation strategies on thyroid function in iodine-deficient pregnant women: a meta-analysis
This meta-analysis found that iodine supplementation during pregnancy significantly reduced maternal serum TSH and thyroglobulin, especially in Asian women, third trimester, and with 200–300 μg/day potassium iodide, but did not significantly affect FT3, FT4, thyroid antibodies, …
DOI: 10.3389/fpubh.2026.1846475 -
Effects of an Iodine-Containing Prenatal Multiple Micronutrient on Maternal and Infant Iodine Status and Thyroid Function: A Randomized Trial in The Gambia
In a randomized sub-analysis of the ENID trial, prenatal iodine supplementation produced no significant differences in maternal thyroid function, breast milk iodine concentration, or postpartum urinary iodine.
DOI: 10.1089/thy.2019.0789 -
Supplementary Iodine Fails to Reverse Hypothyroidism in Adolescents and Adults with Endemic Cretinism*
This study investigates the efficacy of supplemental iodine in reversing hypothyroidism in adolescents and adults with endemic cretinism, finding that it does not improve thyroid function or associated clinical features.
DOI: 10.1210/jcem-70-2-336 -
Iodine Intake and Maternal Thyroid Function During Pregnancy
This study investigates the association between maternal iodine intake and thyroid function during early pregnancy in three regions of Spain, revealing that high iodine supplement intake may lead to maternal thyroid dysfunction even in iodine-sufficient populations.
DOI: 10.1097/EDE.0b013e3181c1592b -
Iodine Supplementation Decreases Hypercholesterolemia in Iodine-Deficient, Overweight Women: A Randomized Controlled Trial ,
This randomized controlled trial demonstrates that iodine supplementation significantly reduces serum TSH levels and improves lipid profiles, particularly total cholesterol, in overweight, iodine-deficient Moroccan women.
DOI: 10.3945/jn.115.213439 -
Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia
This study investigates the effects of molecular iodine on testosterone-induced oxidative stress and prostatic hyperplasia in male Wistar rats, demonstrating that iodine supplementation can prevent hyperplasia and oxidative stress through inhibition of nitric oxide synthase and …
DOI: 10.1016/j.freeradbiomed.2017.12.014 -
Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: Outcomes of 1300 patients
In a single-center Japanese cohort of 1313 men, iodine-125 prostate brachytherapy with or without external beam radiotherapy achieved 93.5% 7-year biochemical freedom from failure, with risk-group and dose-related gradients and low severe toxicity.
DOI: 10.1016/j.brachy.2014.06.008 -
Uptake and antitumoral effects of iodine and 6‐iodolactone in differentiated and undifferentiated human prostate cancer cell lines
This study investigates the uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines, demonstrating that both forms of iodine can inhibit cell proliferation and induce apoptosis in a dose-dependent manner.
DOI: 10.1002/pros.22536 -
Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
This study identifies predictors of biochemical tumor control and presents an updated prognostic nomogram for patients with clinically localized prostate cancer treated with brachytherapy, demonstrating excellent outcomes across risk groups.
DOI: 10.1016/j.brachy.2011.08.003 -
Urinary iodine concentration: a biochemical parameter for assessing the iodine status
Urinary iodine concentration (UIC) is presented as a practical biomarker for assessing population iodine status, with WHO/ICCIDD thresholds distinguishing deficiency and excess and evidence that breast milk iodine concentration (BMIC) correlates with UIC to support public health…
DOI: 10.3329/mediscope.v5i2.37146